Top Markets
Coin of the day
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Rang in Aktien #32247
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Aktienkurs
$4.65
Zuletzt synchronisiert: 2024-07-24
Marktkapitalisierung
$10.63M
Veränderung (1 Tag)
6.66%
Veränderung (1 Jahr)
0.00%
Land
AU
Handel Medlab Clinical Limited (MDC)

Kategorie

Aktien-Split-Historie für Medlab Clinical Limited (MDC)
Die Aktie Medlab Clinical Limited (Symbol: MDC) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 18, 2026 statt.
Eine MDC-Aktie, die vor dem Aug 18, 2026 gekauft wurde, entspricht heute 0 MDC-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE